¡Ya estamos en !
Descubre más
SYNH
Syneos Health, Inc. Class A Common Stock
Excluida de cotización
SYNH dejó de cotizar en bolsa el 27 de septiembre de 2023.
Acerca de: Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.
Empleados: 29,395
Noticias
Positivo
Neutral
Negativo
Sentimiento
3 meses
Positivo
0%
Neutral
0%
Negativo
0%
No hemos recibido artículos de noticias recientes sobre SYNH.
Gráficos de precios implementados con Lightweight Charts™